Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2013 | 2012
Number of items: 13.

2022

Beelen, Dietrich W., Stelljes, Matthias, Remenyi, Peter, Wagner-Drouet, Eva-Maria, Dreger, Peter, Bethge, Wolfgang, Ciceri, Fabio, Stoelzel, Friedrich, Junghanss, Christian, Labussiere-Wallet, Helene, Schaefer-Eckart, Kerstin, Grigoleit, Goetz U., Scheid, Christof, Patriarca, Francesca, Rambaldi, Alessandro ORCID: 0000-0002-3739-7502, Niederwieser, Dietger, Hilgendorf, Inken ORCID: 0000-0003-2038-9730, Russo, Domenico, Socie, Gerard, Holler, Ernst, Glass, Bertram, Casper, Jochen, Wulf, Gerald, Basara, Nadezda, Bieniaszewska, Maria, Stuhler, Gernot, Verbeek, Mareike, La Rocca, Ursula ORCID: 0000-0002-1990-9973, Finke, Juergen, Benedetti, Fabio, Pichlmeier, Uwe, Klein, Anja, Baumgart, Joachim and Markiewicz, Miroslaw ORCID: 0000-0002-8550-8908 (2022). Treosulfan compared with reduced-intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial. Am. J. Hematol., 97 (8). S. 1023 - 1035. HOBOKEN: WILEY. ISSN 1096-8652

Bethge, Wolfgang A., Martus, Peter, Schmitt, Michael, Holtick, Udo, Subklewe, Marion, von Tresckow, Bastian ORCID: 0000-0003-1410-4487, Ayuk, Francis, Wagner-Drouet, Eva Marie, Wulf, Gerald G., Marks, Reinhard, Penack, Olaf, Schnetzke, Ulf, Koenecke, Christian, von Bonin, Malte ORCID: 0000-0002-2995-3230, Stelljes, Matthias, Glass, Bertram, Baldus, Claudia D., Vucinic, Vladan ORCID: 0000-0002-8398-285X, Mougiakakos, Dimitrios, Topp, Max, Fante, Matthias A., Schroers, Roland, Bayir, Lale, Borchmann, Peter, Buecklein, Veit, Hasenkamp, Justin, Hanoun, Christine, Thomas, Simone, Beelen, Dietrich W., Lengerke, Claudia, Kroeger, Nicolaus and Dreger, Peter (2022). GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany. Blood, 140 (4). S. 349 - 359. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

2021

Frontzek, Fabian ORCID: 0000-0003-1705-3638, Ziepert, Marita, Nickelsen, Maike, Altmann, Bettina, Glass, Bertram, Haenel, Mathias, Truemper, Lorenz, Held, Gerhard, Bentz, Martin, Borchmann, Peter, Dreyling, Martin, Viardot, Andreas, Kroschinsky, Frank P., Metzner, Bernd, Staiger, Annette M., Horn, Heike, Ott, German, Rosenwald, Andreas, Loeffler, Markus, Lenz, Georg and Schmitz, Norbert (2021). Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial. Lancet Haematol., 8 (4). S. E267 - 11. OXFORD: ELSEVIER SCI LTD. ISSN 2352-3026

Liebers, Nora, Duell, Johannes, Fitzgerald, Donnacha ORCID: 0000-0003-4927-7484, Kerkhoff, Andrea, Noerenberg, Daniel, Kaebisch, Eva ORCID: 0000-0001-7752-4126, Acker, Fabian ORCID: 0000-0002-6207-0237, Fuhrmann, Stephan ORCID: 0000-0002-7785-2565, Leng, Corinna, Welslau, Manfred, Chemnitz, Jens, Middeke, Jan-Moritz, Weber, Thomas, Holtick, Udo, Trappe, Ralf, Pfannes, Roald, Liersch, Ruediger, Spoer, Christian, Fuxius, Stefan, Gebauer, Niklas, Caille, Leandra, Geer, Thomas, Koenecke, Christian, Keller, Ulrich, Claus, Rainer, Mougiakakos, Dimitrios, Mayer, Stephanie, Huettmann, Andreas, Pott, Christiane, Trummer, Arne, Wulf, Gerald, Brunnberg, Uta, Bullinger, Lars ORCID: 0000-0002-5890-5510, Hess, Georg, Mueller-Tidow, Carsten, Glass, Bertram, Lenz, Georg, Dreger, Peter and Dietrich, Sascha (2021). Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas. Blood Adv., 5 (13). S. 2707 - 2717. AMSTERDAM: ELSEVIER. ISSN 2473-9537

2020

Beelen, Dietrich Wilhelm, Trenschel, Rudolf, Stelljes, Matthias, Groth, Christoph, Masszi, Tamas, Remenyi, Peter, Wagner-Drouet, Eva-Maria, Hauptrock, Beate, Dreger, Peter, Luft, Thomas, Bethge, Wolfgang, Vogel, Wichard, Ciceri, Fabio, Peccatori, Jacopo, Stoelzel, Friedrich, Schetelig, Johannes, Junghanss, Christian, Grosse-Thie, Christina, Michallet, Mauricette, Labussiere-Wallet, Helene, Schaefer-Eckart, Kerstin, Dressler, Sabine, Grigoleit, Goetz Ulrich, Mielke, Stephan ORCID: 0000-0002-8325-9215, Scheid, Christof, Holtick, Udo, Patriarca, Francesca, Medeot, Marta, Rambaldi, Alessandro, Mico, Maria Caterina, Niederwieser, Dietger, Franke, Georg-Nikolaus, Hilgendorf, Inken ORCID: 0000-0003-2038-9730, Winkelmann, Nils Rudolf, Russo, Domenico, Socie, Gerard, de Latour, Regis Peffault, Holler, Ernst, Wolff, Daniel, Glass, Bertram, Casper, Jochen, Wulf, Gerald, Menzel, Helge, Basara, Nadezda, Bieniaszewska, Maria, Stuhler, Gernot, Verbeek, Mareike, Grass, Sandra, Iori, Anna Paola, Finke, Juergen, Benedetti, Fabio, Pichlmeier, Uwe, Hemmelmann, Claudia, Tribanek, Michael, Klein, Anja, Mylius, Heidrun Anke, Baumgart, Joachim, Dzierzak-Mietla, Monika and Markiewicz, Miroslaw (2020). Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial. Lancet Haematol., 7 (1). S. E28 - 12. OXFORD: ELSEVIER SCI LTD. ISSN 2352-3026

2019

Huebel, Kai, Ostermann, H., Glass, Bertram, Noppeney, Richard, Kron, Florian, Kron, Anna, Milkovich, Gary and Mohty, Mohamad (2019). Plerixafor in non-Hodgkin's lymphoma patients: a German analysis of time, effort and costs. Bone Marrow Transplant., 54 (1). S. 123 - 130. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365

Poeschel, Viola, Held, Gerhard, Ziepert, Marita, Witzens-Harig, Mathias, Holte, Harald, Thurner, Lorenz, Borchmann, Peter, Viardot, Andreas, Soekler, Martin, Keller, Ulrich, Schmidt, Christian, Truemper, Lorenz, Mahlberg, Rolf, Marks, Reinhard, Hoeffkes, Heinz-Gert, Metzner, Bernd, Dierlamm, Judith, Frickhofen, Norbert, Haenel, Mathias, Neubauer, Andreas, Kneba, Michael, Merli, Francesco, Tucci, Alessandra ORCID: 0000-0003-3052-7463, Brown, Peter de Nully ORCID: 0000-0002-6522-4086, Federico, Massimo, Lengfelder, Eva, di Rocco, Alice, Trappe, Ralf ORCID: 0000-0001-7565-7160, Rosenwald, Andreas, Berdel, Christian, Maisenhoelder, Martin, Shpilberg, Ofer, Amam, Josif, Christofyllakis, Konstantinos ORCID: 0000-0002-0308-388X, Hartmann, Frank, Murawski, Niels, Stilgenbauer, Stephan, Nickelsen, Maike, Wulf, Gerald, Glass, Bertram, Schmitz, Norbert, Altmann, Bettina, Loeffler, Markus and Pfreundschuh, Michael (2019). Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial. Lancet, 394 (10216). S. 2271 - 2282. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-547X

2018

Mohty, Mohamad, Azar, Nabih, Chabannon, Christian ORCID: 0000-0002-3755-4889, Le Gouill, Steven, Karlin, Lionel, Farina, Lucia, Milkovich, Gary, Ostermann, Helmut, Glass, Bertram, Noppeney, Richard, Kron, Florian, Kron, Anna and Huebel, Kai (2018). Plerixafor in poor mobilizers with non-Hodgkin's lymphoma: a multi-center time-motion analysis. Bone Marrow Transplant., 53 (3). S. 246 - 255. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365

Santoro, Nicole, Labopin, Myriam, Giannotti, Federica, Ehninger, Gerard, Niederwieser, Dietger, Brecht, Arne, Stelljes, Matthias, Kroeger, Nicolaus, Einsele, Herman, Eder, Matthias, Hallek, Michael, Glass, Bertram, Finke, Juergen, Ciceri, Fabio, Mohty, Mohamad, Ruggeri, Annalisa and Nagler, Arnon (2018). Unmanipulated haploidentical in comparison with matched unrelated donor stem cell transplantation in patients 60 years and older with acute myeloid leukemia: a comparative study on behalf of the ALWP of the EBMT. J. Hematol. Oncol., 11. LONDON: BIOMED CENTRAL LTD. ISSN 1756-8722

2017

Heidenreich, Silke, Ziagkos, Dimitris, de Wreede, Liesbeth C., van Biezen, Anja, Finke, Juergen, Platzbecker, Uwe, Niederwieser, Dietger, Einsele, Hermann, Bethge, Wolfgang, Schleuning, Michael, Beelen, Dietrich W., Tischer, Johanna, Nagler, Arnon, Glass, Bertram, Maertens, Johan, Yanez, Lucrecia, Beguin, Yves, Sill, Heinz ORCID: 0000-0003-0993-4371, Scheid, Christof, Stelljes, Matthias, Ganser, Arnold, Zachee, Pierre ORCID: 0000-0002-2275-5143, Selleslag, Dominik, de Witte, Theo, Robin, Marie ORCID: 0000-0003-1388-9876 and Kroeger, Nicolaus (2017). Allogeneic Stem Cell Transplantation for Patients Age >= 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT. Biol. Blood Marrow Transplant., 23 (1). S. 44 - 53. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1523-6536

2015

Schmitz, Norbert, Nickelsen, Maike, Ziepert, Marita, Haenel, Mathias, Viardot, Andreas, Dreyling, Martin H., Borchmann, Peter, Bokemeyer, Carsten, Peschel, Christian, Wolf, Hans-Heinrich, Mahlberg, Rolf, Pfreundschuh, Michael and Glass, Bertram (2015). Optimization of Rituximab for Treatment of DLBCL in Young, High-Risk Patients-Results of the Dense-R-CHOEP Trial of the German High-Grade Lymphoma Study Group. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

2013

Held, Gerhard, Zeynalova, Samira, Murawski, Niels, Ziepert, Marita, Kempf, Barbara, Viardot, Andreas, Dreyling, Martin, Hallek, Michael, Witzens-Harig, Mathias ORCID: 0000-0002-2799-4661, Fleckenstein, Jochen, Ruebe, Christian, Zwick, Carsten, Glass, Bertram, Schmitz, Norbert and Pfreundschuh, Michael (2013). Impact of Rituximab and Radiotherapy on Outcome of Patients With Aggressive B-Cell Lymphoma and Skeletal Involvement. J. Clin. Oncol., 31 (32). S. 4115 - 4126. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

2012

Schmitz, Norbert, Nickelsen, Maike, Ziepert, Marita, Haenel, Mathias, Borchmann, Peter, Schmidt, Christian, Viardot, Andreas, Bentz, Martin, Peter, Norma, Ehninger, Gerhard, Doelken, Gottfried, Ruebe, Christian, Truemper, Lorenz, Rosenwald, Andreas, Pfreundschuh, Michael, Loeffler, Markus and Glass, Bertram (2012). Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1). Lancet Oncol., 13 (12). S. 1250 - 1260. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1470-2045

This list was generated on Fri Mar 29 06:31:17 2024 CET.